TCER AB is a privately held biopharmaceutical company based in Stockholm, Sweden. 

TCER AB conducts its research in close cooperation with the research group Therapeutic Immune Design at the Centre for Molecular Medicine at Karolinska Institute. We are focussing our efforts to develop personalized immunotherapy for cancer and multiple sclerosis using our unique clinical network and proprietary technology.